Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib plus carboplatin and paclitaxel versus investigator's choice chemotherapy in first-line advanced non-squamous NSCLC in smokers
NL-OMON47385Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of veliparib, sponsored by AbbVie Inc. Started Jul 2015; status: completed.
02
Drugs
veliparib
Beyond the preview
Go deeper on NL-OMON47385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47385.